Seguimiento telemático de COVID-19: experiencia de un hospital terciario
Javier Nogueira López, Carlos Grasa Lozano, Cristina Ots Ruiz, Luis Alonso García, Iker Falces-Romero, Cristina Calvo, Milagros García-López Hortelano
Anales de Pediatría, doi:10.1016/j.anpedi.2020.10.017
Resumen Introducción: El seguimiento telefónico es una posible alternativa para la atención médica de niños con COVID-19. Nuestro objetivo es describir la experiencia del seguimiento telemático realizado en un hospital terciario. Pacientes y métodos: Estudio descriptivo retrospectivo de los niños con diagnóstico confirmado o probable de COVID-19 atendidos en la consulta de seguimiento del Hospital La Paz entre marzo y junio del 2020. Se realizaron llamadas cada 48 h hasta desaparecer los síntomas y posteriormente semanales hasta estar 14 días asintomáticos. Resultados: Se incluyó a 72 niños con una mediana de edad de 83,5 meses (RIC = 16,3-157,5); 46 eran varones (63,9%) y 14 tenían comorbilidades (19,4%); 32 pacientes (44,4%) habían requerido ingreso hospitalario. Se confirmó diagnóstico de COVID-19 en 33 niños por PCR y en 7 por serología. De los confirmados por PCR, seroconvirtió el 67,7%. Se demostraron otras etiologías en 7 pacientes (5 Mycoplasma pneumoniae, uno parvovirus y uno citomegalovirus). La mediana de duración de síntomas fue 25,5 días (RIC = 13,8-37), con mediana de tiempo de seguimiento de 28 días (RIC = 21-39). Se realizó una mediana de 6 llamadas (RIC = 4-8) por niño; 19 pacientes (26,4%) refirieron empeoramiento en el seguimiento, precisando 14 (19,4%) ser revaluados en Urgencias. Un niño necesitó reingresar, siendo la evolución favorable.
References
Bastos, Tavaziva, Abidi, Campbell, Haraoui et al., Diagnostic accuracy of serological tests for covid-19: Systematic review and meta-analysis, BMJ
Bwire, Majigo, Njiro, Mawazo, Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis, J Med Virol,
doi:10.1002/jmv.26349Cavalcanti, Zampieri, Rosa, Azevedo, Veiga et al., Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19, N Engl J Med,
doi:10.1056/NEJMoa2019014Colmenero, Santonja, Alonso-Riaño, Noguera-Morel, Hernández-Martín et al., SARS-CoV-2 endothelial infection causes COVID-19 chilblains: Histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases, Br J Dermatol,
doi:10.1111/bjd.19327Dong, Mo, Hu, Qi, Jiang et al., Epidemiology of COVID-19 among children in China, Pediatrics
Gallais, Velay, Wendling, Nazon, Partisani et al., Intrafamilial Exposure to SARS-CoV-2 induces cellular immune response without seroconversion, medRxiv
Gottlieb, Long, Dermatologic manifestations and complications of COVID-19, Am J Emerg Med
Guessoum, Lachal, Radjack, Carretier, Minassian et al., Adolescent psychiatric disorders during the COVID-19 pandemic and lockdown, Psychiatry Res
Götzinger, Santiago-García, Noguera-Julián, Lanaspa, Lancella et al., COVID-19 in children and adolescents in Europe: A multinational, multicentre cohort study, Lancet Child Adolesc Health
Hoang, Chorath, Moreira, Evans, Burmeister-Morton et al., COVID-19 in 7780 pediatric patients: A systematic review, EClinicalMedicine
Li, Yao, Li, Chen, Song et al., Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19, J Med Virol,
doi:10.1002/jmv.26349Meng, Deng, Dai, Meng, COVID-19 and anosmia: A review based on up-to-date knowledge, Am J Otolaryn
Otto, Geoghegan, Posch, Bell, Coffin et al., The epidemiology of SARS-CoV-2 in a Pediatric Healthcare Network in the United States, J Pediatric Infect Dis Soc
Pollán, Pérez-Gómez, Pastor-Barriuso, Oteo, Hernán et al., Prevalence of SARS-CoV-2 in Spain (ENE-COVID): A nationwide, population-based seroepidemiological study, Lancet
Poncet-Megemont, Paris, Tronchere, Salazard, Pereira et al., High prevalence of headaches during Covid-19 infection: A retrospective cohort study, Headache,
doi:10.1111/head.13923Recovery Collaborative Group, Horby, Mafham, Linsell, Bell et al., Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19, N Engl J Med
Rosenberg, Dufort, Udo, Wilberschied, Kumar et al., Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State, JAMA
Sekine, Perez-Potti, Rivera-Ballesteros, Strålin, Gorin et al., Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19, Cell
Spinato, Fabbris, Polesel, Cazzador, Borsetto et al., Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection, JAMA
Tenforde, Kim, Lindsell, Rose, Shapiro et al., Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network-United States, MMWR Morb Mortal Wkly Rep
Wajnberg, Mansour, Leven, Bouvier, Patel et al., Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study, Lancet Microbe
Walsh, Jordan, Clyne, Rohde, Drummond et al., SARS-CoV-2 detection, viral load and infectivity over the course of an infection, J Infect
Who Director, General's opening remarks at the media briefing on COVID-19
Who Director, General's opening remarks at the media briefing on COVID-19. 13
Wikramaratna, Paton, Ghafari, Lourenco, Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR
Younes, Al-Sadeq, Al-Jighefee, Younes, Al-Jamal et al., Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2, Viruses
